These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29549023)

  • 1. Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles.
    Kennedy PJ; Perreira I; Ferreira D; Nestor M; Oliveira C; Granja PL; Sarmento B
    Eur J Pharm Biopharm; 2018 Jun; 127():366-370. PubMed ID: 29549023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of surfactants on the properties of PLGA nanoparticles.
    Menon JU; Kona S; Wadajkar AS; Desai F; Vadla A; Nguyen KT
    J Biomed Mater Res A; 2012 Aug; 100(8):1998-2005. PubMed ID: 22566409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLGA nanoparticles for peroral delivery: How important is pancreatic digestion and can we control it?
    Mante A; Heider M; Zlomke C; Mäder K
    Eur J Pharm Biopharm; 2016 Nov; 108():32-40. PubMed ID: 27553262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
    Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium Stearate as an Effective Alternative to Poly(vinyl alcohol) in Poly-Lactic-co-Glycolic Acid Nanoparticles Synthesis.
    Cella C; Gerges I; Milani P; Lenardi C; Argentiere S
    Biomacromolecules; 2017 Feb; 18(2):452-460. PubMed ID: 28030952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments.
    Turk CT; Oz UC; Serim TM; Hascicek C
    AAPS PharmSciTech; 2014 Feb; 15(1):161-76. PubMed ID: 24222270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
    Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
    J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles using sodium carboxymethyl cellulose as colloidal stabilize.
    Chittasupho C; Thongnopkoon T; Kewsuwan P
    Curr Drug Deliv; 2016; 13(1):95-104. PubMed ID: 26338259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
    Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells.
    Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
    Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
    Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved delivery of the natural anticancer drug tetrandrine.
    Shi C; Ahmad Khan S; Wang K; Schneider M
    Int J Pharm; 2015 Feb; 479(1):41-51. PubMed ID: 25510598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6.
    Kennedy PJ; Sousa F; Ferreira D; Pereira C; Nestor M; Oliveira C; Granja PL; Sarmento B
    Acta Biomater; 2018 Nov; 81():208-218. PubMed ID: 30267881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
    Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells.
    Punfa W; Yodkeeree S; Pitchakarn P; Ampasavate C; Limtrakul P
    Acta Pharmacol Sin; 2012 Jun; 33(6):823-31. PubMed ID: 22580738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells.
    Grabowski N; Hillaireau H; Vergnaud J; Santiago LA; Kerdine-Romer S; Pallardy M; Tsapis N; Fattal E
    Int J Pharm; 2013 Oct; 454(2):686-94. PubMed ID: 23747506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.